TY  - JOUR 
AU  - Genovese, M. C.
AU  - van der Heijde, D.
AU  - Lin, Y.
AU  - St John, G.
AU  - Wang, S.
AU  - van Hoogstraten, H.
AU  - Gómez-Reino Carnota, Juan Jesús
AU  - Kivitz, A.
AU  - Maldonado-Cocco, J. A.
AU  - Seriolo, B.
AU  - Stanislav, M.
AU  - Burmester, G. R.
PY  - 2019
SN  - 2056-5933
UR  - http://hdl.handle.net/20.500.11940/15467
AB  - Objective: In MOBILITY (NCT01061736), sarilumab significantly reduced disease activity, improved physical function and inhibited radiographic progression at week 52 versus placebo in patients with rheumatoid arthritis (RA) and an inadequate response...
LA  - eng
KW  - Arthritis, Rheumatoid
KW  - Antirheumatic Agents
KW  - Antibodies, Monoclonal, Humanized
TI  - Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment
DO  - 10.1136/rmdopen-2018-000887
T2  - RMD Open
M2  - e000887
KW  - CHUS
VL  - 5
ER  -